• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CONTRIBUTI SCIENTIFICI – Scientific Papers

Volume:

Biochimica Clinica 2020; 44(4) 367-373

Pubblicato on-line:

October 15, 2020

DOI:

10.19186/BC_2020.061

Scarica in PDF:

Titolazioni dei preparati galenici oleosi a base di cannabis in Regione Liguria: progetto sperimentale dei laboratori di riferimento regionale
Analysis of cannabinoids concentration in cannabis oil galenic preparations in the Liguria Region: experimental project of the regional reference laboratories

AUTORI

Giuliana Cangemi1*, Paolo Bucchioni2*, Gino Tripodi1*, Sebastiano Barco1, Paolo Franceschini2, Isa Mavi Sbarbaro2, Gianfranco Petricciani2, Laura Barbagallo1, Angelo Maffia1, Eugenia Livoti4, Clara Cannas4, Eleonora Russo3*, Barbara Rebesco4*, Flavia Lillo5*
1Laboratorio Centrale di Analisi, IRCCS Istituto Giannina Gaslini, Genova
2Laboratorio di Tossicologia, Ospedale San Bartolomeo, ASL5 Spezzino, Sarzana
3Dipartimento di Farmacia, Università degli Studi di Genova
4Struttura Complessa Politiche del Farmaco, A.Li.Sa (Agenzia Ligure Sanitaria), Regione Liguria
5MacroArea dei laboratori, DIAR dei servizi Trasfusionale, Laboratori e Diagnostica Clinica per Immagini, A.Li.Sa (Agenzia Ligure Sanitaria), Regione Liguria
*Per conto del gruppo di lavoro “Titolazione delle preparazioni galeniche oleose a base di cannabis“ di A.Li.Sa (Agenzia Ligure Sanitaria) composto da: Barbara Rebesco, Maria Susanna Rivetti, Gabriella Paoli, Flavia Lillo, Eleonora Russo, Paolo Bucchioni, Gino Tripodi, Giuliana Cangemi, Paola Barabino, Valentina Iurilli, Marinella Bedo, Sara Macis, Simona Peri, Clara Cannas.

ABSTRACT

Analysis of cannabinoids concentration in cannabis oil galenic preparations in the Liguria Region: experimental project of the regional reference laboratories

Introduction: the medical use of cannabis is increasingly being applied in the treatment and support of several diseases and syndromes. In the Liguria Region, olive oil galenic preparations are mainly prepared by hospital pharmacies, according to common standard procedures. The preparations must be analyzed in order to establish the concentration of the two main active compounds (delta-9 tetrahydrocannabinol, THC and cannabidiol, CBD) thus allowing the correct setting of the therapeutic prescription. Liguria Region is at the forefront in the use of medical cannabis with a high number of patients treated (>1000). The aim of this work is to describe the organization of the titration activity centralized at the two regional reference laboratories (Central Laboratory of Analyses of Giannina Gaslini Institute, Genova and Toxicology Laboratory of Sarzana, La Spezia), coordinated by the inter-hospital department (DIAR) of the Laboratories Area.
Methods: the phases of the analytical process (pre-analytical, analytical and post-analytical) have been identified and described. The analysis of the workflow has been carried out including the methods to prepare cannabis oil in the pharmacies, the intervals and production volumes, the medical-legal handling requirements and operational responsibilities. The definition of the pre-analytical phase foresees the methods of packaging, transport and recording of the samples and related responsibilities.
Results: the analytical phase included the development and validation of the analytical method Ultra High Performance Liquid Chromatography coupled to tandem mass spectrometry, (UHPLC-MS/MS) in the two laboratories, with common procedures and the comparison of results conducted both on reference material and real samples of olive oil galenic preparations. The definition of the post-analytical phase included the reporting procedures.
Discussion: the experimental phase has been concluded at the end of 2019 and the implementation phase of the project has started in march 2020.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967